Gabelli Funds’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Gabelli Funds’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-24,434	Closed	-$7.28K	–	1229
2022 Q4	$7.28K	Hold	24,434	–	–	﹤0.01%	1149
2022 Q3	$2K	Hold	24,434	–	–	﹤0.01%	1316
2022 Q2	$4K	Hold	24,434	–	–	﹤0.01%	1347
2022 Q1	$5K	Hold	24,434	–	–	﹤0.01%	1417
2021 Q4	$15K	Hold	24,434	–	–	﹤0.01%	1398
2021 Q3	$15K	Buy	+24,434	New	+$19K	﹤0.01%	1379

Gabelli Funds's EBACW Position: Q1 2023 in Review

Gabelli Funds sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 24,434 shares — an estimated $7.28K sold.

Gabelli Funds first reported a position in EBACW in Q3 2021 and held it in 6 quarters. The position peaked at $15K in Q4 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Gabelli Funds reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Gabelli Funds sold 24,434 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $7.28K.
Gabelli Funds first reported a position in European Biotech Acquisition Corp. Warrant in Q3 2021 and held it in 6 quarters.
Gabelli Funds's European Biotech Acquisition Corp. Warrant position peaked at $15K in Q4 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Gabelli Funds's 13F filing for Q1 2023, filed 12 May 2023.